Word

ONCOLYTIC IMMUNOTHERAPY

Status

Pending

Status Code

630

Status Date

Sunday, March 17, 2024

Serial Number

98452032

Mark Type

4000

Filing Date

Friday, March 15, 2024

Trademark Owner History

CG Oncology, Inc.

Classifications

5 Pharmaceutical products for the treatment of cancer; pharmaceutical preparations and biological preparations for the treatment of cancer and immunological disorders; Biopharmaceuticals for the treatment of cancer, namely, antibodies, non-antibody proteins, blood and blood components, stem cells, hormones, blood factors, tumor necrosis factors; Chemical preparations for medical or pharmaceutical purposes, namely, for cancer treatment, oncology and immunotherapy for auto immune diseases; Pharmaceutical products, namely, diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing

42 Pharmaceutical research and development; Providing medical and scientific research information in the fields of oncology, autoimmune disorders; immunotherapy, immunotherapeutics, biotechnology, biopharmaceuticals, pharmaceuticals, therapies, diseases, and disorders

Trademark Events

Mar 17, 2024

New Application Entered